ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
15 Marzo 2024 - 1:05AM
UK Regulatory
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
- 36,000 people across 17 markets responded to the company’s
fourth annual survey.
- 40% of respondents get no more than three nights of good
sleep per week.
- More than one-third of respondents are now actively
tracking their sleep patterns, and many are adjusting bedtime
routines in an effort to improve sleep quality.
SAN DIEGO, March 15, 2024 (GLOBE NEWSWIRE) --
ResMed (NYSE: RMD, ASX: RMD), the global leader in digital health
and cloud-connected medical devices that transform care for people
with sleep apnea, COPD, and other chronic diseases, today announced
the results of its 2024 Global Sleep Survey in conjunction with
World Sleep Day (March 15), shedding light on the critical sleep
challenges faced by people around the world.
The survey uncovered a staggering number of
people suffering from a chronic lack of good sleep, with nearly 40%
of respondents getting no more than three nights of good sleep each
week – and some individuals reporting just one. Respondents
reported feeling excessive daytime sleepiness (50%), negative
feelings in the morning (40%) and more irritable (39%).
In its fourth year, the survey is core to
ResMed’s Discover Your Sleep Superpowers campaign and this
year’s findings are even more comprehensive, with 36,000
participants across 17 markets providing insights on the state of
sleep around the world.
A world in sleep crisis*
- Across the
surveyed population, only 13% of respondents reported sleeping well
every night. People in Japan (57%) topped the list for the number
of poor nights’ sleep each week while people in India were the most
rested with 27% saying they sleep well every night.
- Over half of our
respondents used a digital device before going to bed, whether to
scroll through social media (53%), watch TV (44%) or catch up on
news (31%).
- When asked about
what was keeping them awake, the top reasons that emerged were
personal anxiety (36%), insomnia (25%), breathing difficulties
(15%), and obesity (13%).
- Even after
falling asleep, 3 in 10 respondents reported being unable to stay
asleep without being woken up. People in the UK (44%) and France
(42%) experienced the most disruption to their sleep while
respondents from India (42%) and Thailand (41%) were most likely to
fall and stay asleep the entire night.
- Among female
respondents who are perimenopausal or menopausal, 56% suffer from
disturbed sleep, with women in Ireland and Australia being the most
affected. In both countries, 3 in 4 women that are perimenopausal
or menopausal said they suffer from disturbed sleep.
Discover your sleep
superpowers
- The top three
benefits experienced by respondents after a night of good sleep
were improved concentration (50%), increased productivity (51%) and
improved mental health (44%).
- Nearly 9 in 10
respondents also said that good sleep benefits them physically
while 83% agree that good sleep enables them to be more
creative.
- People are also
becoming more curious about how they sleep, with 36% of respondents
tracking their sleep either through a smartphone app (44%) or
wearable (31%).
“With sleep being the third pillar of health,
alongside diet and exercise, prioritizing your sleep is one of the
most effective ways to improve your overall health,” said Carlos,
M. Nunez. M.D., ResMed Chief Medical Officer. “With over 936
million people around the world affected by sleep
apnea1, it is concerning to learn that 40% of the people
we surveyed get no more than three good nights of sleep a week.
Poor sleep can be an indicator of conditions such as insomnia and
sleep apnea, so this World Sleep Day we want to empower people to
take charge of their sleep health and have conversations with their
healthcare provider.”
Among survey respondents, 57% claim they are
aware of sleep apnea, a chronic disease in which the muscles of the
throat relax to the point of collapse, restricting airflow and
causing the sufferer to stop breathing repeatedly throughout the
night. Notably, however, only 26% of those respondents have been
diagnosed.
To learn more about ResMed’s 2024 Global Sleep
Survey or for help identifying if you have symptoms that could
indicate poor sleep health, visit
https://www.resmed.com/sleepassessment.
Survey Methodology
The 2024 ResMed Global Sleep Survey included a
total of 36,000 respondents across 17 markets including Australia,
Brazil, China, France, Germany, Hong Kong, India, Ireland, Japan,
Korea, Mexico, New Zealand, Singapore, Taiwan, Thailand, UK and
USA, between December 2023 and January 2024.
About ResMed
At ResMed we pioneer innovative solutions that
treat and keep people out of the hospital, empowering them to live
healthier, higher-quality lives. Our digital health technologies
and cloud-connected medical devices transform care for people with
sleep apnea, COPD, and other chronic diseases. Our comprehensive
out-of-hospital software platforms support the professionals and
caregivers who help people stay healthy in the home or care setting
of their choice. By enabling better care, we improve quality of
life, reduce the impact of chronic disease, and lower costs for
consumers and healthcare systems in more than 140 countries. To
learn more, visit ResMed.com and follow @ResMed.
Contacts
For
media
+1
858.289.7272
news@resmed.com
For investors
+1 858.836.5000
investorrelations@resmed.com
1 Benjafield A et al. Lancet Respir Med
2019)
*Based on 36,000 respondents across 17 markets surveyed as part of
the ResMed 2024 Global Sleep Survey between December 2023 and
January 2024
Resmed (LSE:0KW4)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Resmed (LSE:0KW4)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024